Benchmark Company

In a report published Wednesday, Benchmark analyst Daniel L. Kurnos reiterated a Buy rating on 1-800-FLOWERS (NASDAQ: FLWS), and raised the price target from $6.50 to $8.00. In the report, Benchmark noted, “We recently hosted 1-800-FLOWERS.com (FLWS-Buy) in Philadelphia. We believe Flowers...

In a report published Wednesday, Benchmark Company analyst Gary Mobley reiterated a Buy rating and $6.00 price target on Entropic Communications (NASDAQ: ENTR). In the report, Benchmark Company noted, “After the market close on Tuesday, Entropic issued mixed news. On one hand, the company...

In a report published Wednesday, Benchmark Company analyst Edward J. Atorino reiterated a Buy rating on Nexstar Broadcasting Group (NASDAQ: NXST), and raised the price target from $21.00 to $39.00. In the report, Benchmark Company noted, “After a slow start, Nexstar's (NXST-Buy, PT from $21 to...

In a report published Monday, Benchmark analyst Gary Mobley downgraded the rating on STEC (NASDAQ: STEC) from Hold to Sell, but reiterated the $4.50 price target. In the report, Benchmark Company noted, “In a move that is not entirely surprising, Western Digital announced the intent to acquire...

In a report published Wednesday, Benchmark Company analyst Gary Mobley initiated coverage on Audience (NASDAQ: ADNC) with a Hold rating and $15.00 price target. In the report, Benchmark Company noted, “We are initiating coverage of Audience, Inc. with a Hold rating and $15.00 price target....

In a report published Monday, Benchmark Company analyst Daniel L. Kurnos reiterated a Buy rating on United Online (NASDAQ: UNTD), and slightly raised the price target from $7.00 to $7.50. In the report, Kurnos noted, “United Online is set to spin off its primary growth asset, FTD, by the end of...

In a report published Monday, Benchmark Company analyst Ronald Bookbinder downgraded the rating on True Religion Apparel (NASDAQ: TRLG) from Buy to Hold, but reiterated the $32.00 price target. In the report, Bookbinder noted, “True Religion has received a bid for $32.00 per share in cash. With...

In a report published Thursday, Benchmark Company analyst James Terwilliger downgraded the rating on ICU Medical (NASDAQ: ICUI) from Buy to Hold, but reiterated the $69.00 price target. In the report, Terwilliger noted, “We are lowering our recommendation to Hold from Buy based on valuation as ICU...

In a report published Thursday, Benchmark Company analyst James Terwilliger initiated coverage on Merit Medical Systems (NASDAQ: MMSI) with a Hold rating and $10.00 price target. In the report, Terwilliger noted, “Our $10.00 price target represents 20 times our adjusted 2013 EPS estimate of $0.53...

In a report published Friday, Benchmark Company analyst Mark W. Schappel downgraded the rating on Guidance Software (NASDAQ: GUID) from Buy to Hold and lowered the price target from $13.00 to $9.00. In the report, Schappel noted, “Management attributed the Q1 revenue shortfall to a lack of urgency...

In a report published Wednesday, Benchmark Company analyst Mark W. Schappel reiterated a Buy rating on E2open (NASDAQ: EOPN), but lowered the price target from $25.00 to $18.00. In the report, Schappel noted, “Last night, EOPN missed consensus estimates for both total revenue and EPS, and lowered...

In a report published Monday, Benchmark Company analyst Edward J. Atorino reiterated a Buy rating on The McGraw-Hill Companies (NYSE: MHP), and raised the price target from $57.00 to $59.00. In the report, Atorino noted, “McGraw Hill recently completed the sale of McGraw Hill Education to...

In a report published Friday, Benchmark Company analyst Mark W. Schappel reiterated a Buy rating and $14.00 price target on Saba Software (NASDAQ: SABA). In the report, Schappel noted, “Last night, SABA announced that it expects to be delisted from the NASDAQ since the company is unable to meet...

In a report published Thursday, Benchmark Company analyst Mark W. Schappel reiterated a Buy rating on Progress Software Corporation (NASDAQ: PRGS), but lowered the price target from $33.00 to $29.00. In the report, Schappel noted, “Last night, PRGS beat F1Q13 consensus revenue estimates and met...

In a report published Wednesday, Benchmark Company analyst Edward J. Atorino reiterated a Buy rating on R.R. Donnelley & Sons Co. (NASDAQ: RRD), and slightly raised the price target from $12.00 to $13.00. In the report, Atorino noted, “Despite the prospect of higher sales than previously...